Status:

COMPLETED

Study of The Effects of Testosterone in Frail Elderly Men

Lead Sponsor:

Manchester University NHS Foundation Trust

Collaborating Sponsors:

University of Manchester

Bayer

Conditions:

Frailty

Sarcopenia

Eligibility:

MALE

65+ years

Phase:

PHASE4

Brief Summary

The study aims to determine the effects of testosterone on muscle function, mobility, activities of daily living and overall quality of life

Detailed Description

Ageing-associated loss of muscle mass and strength is a major cause of physical frailty, disability, morbidity and dependency in the elderly. This is associated with increased falls, fractures, loss o...

Eligibility Criteria

Inclusion

  • Frail elderly men (as defined by Freid's criteria of frailty)
  • Community - dwelling men aged 65 years and above
  • Total testosterone ≤12.0 nmol/L or calculated free T≤0.25nmol/L

Exclusion

  • Carcinoma of prostate
  • Carcinoma of breast
  • PSA \>4ng/mL
  • Severe symptomatic benign prostatic hypertrophy (IPSS \>21)
  • Active liver disease
  • Renal impairment (serum creatinine \>180 mmol/L)
  • Congestive heart failure
  • Unstable ischaemic heart disease
  • Polycythaemia
  • Evidence of systemic disease which may affect muscle/joint function
  • Moderate to severe peripheral vascular disease
  • Moderate to severe chronic obstructive airways disease
  • Alcohol consumption over 30 units per week
  • Medications that interfere with sex steroid metabolism
  • History of stroke causing persistent motor deficit
  • Cognitive deficit
  • Major psychiatric illness
  • Hospital admission in the past 6 weeks
  • Sleep apnoea

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2008

Estimated Enrollment :

262 Patients enrolled

Trial Details

Trial ID

NCT00190060

Start Date

October 1 2004

End Date

December 31 2008

Last Update

August 3 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary

Manchester, United Kingdom, M13 9WL